Judith Klimovsky V.

Insider Reports History

Location
Minneapolis, MN
Signature
/s/ Andrew Nick as Attorney-in-Fact for Judith V. Klimovsky pursuant to Power of Attorney filed previously.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Judith Klimovsky V.:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIO-TECHNE Corp Director Common Stock 3,782 $210,392 $55.63 30 Oct 2025 Direct
BIO-TECHNE Corp Director Stock Option (Right to Buy) 3,777 $210,114 $55.63 30 Oct 2025 Direct
BELLICUM PHARMACEUTICALS, INC Director Stock Option (right to buy) 15,000 $21,600 $1.44 15 Jun 2022 Direct
BELLICUM PHARMACEUTICALS, INC Director Common Stock 110,098 03 Jan 2023 Direct
BELLICUM PHARMACEUTICALS, INC Director Restricted Stock Units 0 04 Jan 2022 Direct

Insider Reports Filed by Judith Klimovsky V.